SCHEMBL246394

SCHEMBL246394

Cc1cc(C)c(C(=O)Cl)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 3/20 0.41
TAS1R1 Q7RTX1 3/20 0.41
TAS1R2 Q8TE23 3/20 0.41
ALDH1A1 P00352 4/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
MAPK1 P28482 2/20 0.39
TPMT P51580 1/20 0.39
MAPT P10636 1/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28612978 0.97 TAS1R3 (0.40) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A
Phosphine SCHEMBL27814958 0.97 TAS1R3 (0.40) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A
SCHEMBL28501367 0.86 KDM4E (0.44) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A
SCHEMBL18033973 0.86 HTT (0.44) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A
SCHEMBL4355570 0.84 CA1 (0.43) ALDH1A1KMT2AHPGDSMN1; SMN2MEN1
SCHEMBL2154502 0.82 ALDH1A1 (0.38) ALDH1A1KMT2AHPGDSMN1; SMN2MEN1
SCHEMBL21870 0.81 KDM4E (0.55) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A
SCHEMBL377596 0.81 KDM4E (0.55) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A
SCHEMBL11452025 0.81 ALDH1A1 (0.36) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A
SCHEMBL7531729 0.81 KMT2A (0.38) TAS1R3TAS1R1TAS1R2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1024 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120025370-A Preparation method of (2, 4, 6-trimethylbenzoyl) diphenyl phosphine oxide 浙江扬帆新材料股份有限公司 2025-05-23 CN claimed
CN-119912373-A (Methyl) acrylic ester monomer and preparation method and application thereof 珠海莫界科技有限公司 2025-05-02 CN claimed
CN-119912372-A (Methyl) acrylic ester monomer and preparation method and application thereof 珠海莫界科技有限公司 2025-05-02 CN claimed
CN-119431168-B Photosensitizer and preparation method and application thereof 广州理文科技有限公司 2025-04-11 CN claimed
CN-115819455-B Acylphosphine oxide compound and preparation method thereof 南方科技大学 2025-03-28 CN claimed
CN-116836304-B Anti-freeze-thawing hydrolysis-resistant ASA papermaking sizing agent emulsion and preparation method thereof 齐鲁工业大学(山东省科学院) 2025-03-25 CN claimed
CN-119518083-A Double-layer polymer solid electrolyte, preparation method thereof and lithium ion battery 南方科技大学 2025-02-25 CN claimed
CN-119431168-A Photosensitizer and preparation method and application thereof 广州理文科技有限公司 2025-02-14 CN claimed
CN-119143802-A (2, 4, 6-Trimethylbenzoyl) (3, 4-xylyl) phenylphosphine oxide photoinitiator and preparation method and application thereof 甘肃青宇新材料有限公司 2024-12-17 CN claimed
CN-117945896-A Continuous rectification production method and device for co-producing benzoyl chloride and 2,4, 6-trimethyl benzoyl chloride 深圳有为技术控股集团有限公司 2024-04-30 CN claimed
CN-103191650-A Manufacturing method of nanofiltration flat sheet membrane containing sodium polystyrene sulfonate SYNDER JIANGYAN MEMBRANE TECHNOLOGY CO LTD 2013-07-10 CN claimed
EP-2288652-B1 PREPARATION FOR INITIATING RADICAL REACTIONS UNITED INITIATORS GMBH & CO KG (DE) 2012-09-19 EP claimed
US-20110272628-A1 Preparation For Initiating Radical Reactions UNITED INITIATORS GMBH (DE) 2011-11-10 US claimed
EP-2288652-A1 PREPARATION FOR INITIATING RADICAL REACTIONS United Initiators GmbH & Co. KG (DE) 2011-03-02 EP claimed
WO-2009146916-A1 PREPARATION FOR INITIATING RADICAL REACTIONS UNITED INITIATORS GMBH & CO. KG (DE) 2009-12-10 WO claimed
EP-2130858-A1 Preparations to initiate radical reactions Degussa Initiators GmbH & Co. KG (DE) 2009-12-09 EP claimed
US-7144993-B2 Process for the preparation of 4-methyl-7-aminoquinolones CIBA SPECIALTY CHEMICALS CORP. (US) 2006-12-05 US claimed
US-20050222397-A1 Process for the preparation of 4-methyl-7-aminoquinolones CIBA SPECIALTY CHEMICALS CORP. 2005-10-06 US claimed
EP-1453809-A1 PROCESS FOR THE PREPARATION OF 4-METHYL-7-AMINOQUINOLONES Ciba SC Holding AG (CH) 2004-09-08 EP claimed
WO-2003050089-A1 PROCESS FOR THE PREPARATION OF 4-METHYL-7-AMINOQUINOLONES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-06-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222397-A1 Process for the preparation of 4-methyl-7-aminoquinolones CBR1, CBR3, MRPL21 TAS1R3 3890/4885TAS1R1 2857/4885TAS1R2 2946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.